Profile of:
John Londono
John Londono is a physician from the Universidad Tecnológica de Pereira, with a degree in Internal Medicine and Rheumatology from the Universidad Militar Nueva Granada. He has a Máster degree in Medical Sciences from the Universidad Autónoma de México and Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán and a PhD in Applied Medical Investigation from the Universidad de Navarra and Centro de Investigación Médica Aplicada in Pamplona, Spain. Doctor Londoño is a full professor in the Universidad de La Sabana and is the developer as well as the current academic head of the rheumatology fellowship from the Universidad de La Sabana. He is a clinical professor from the Universidad Militar Nueva Granada in the rheumatology department and leads the GESPA research group (classified as A by MINCIENCIAS). He is also classified as a Senior Researcher by the same entity and serves as member of the editorial committee of the Revista Colombiana de Reumatología. Doctor Londoño’ s studies focus in the study on Spondyloarthritis in Colombian population, its clinical characterization, clinical and radiological progression and its association with predisposing genetical factors. He is the author of multiple publications in national and international indexed journals. Currently, Doctor Londoño and his research group is working on the undifferentiated, axial non-radiographic and peripheral spondylarthritis subtypes a common clinical presentation in Latin American populations and that need to be contextualized in light of the actual classification criteria of the disease.
Full name: John Londono
Current country: Colombia
Membership level: Associate
Type of membership: Member
Number of publications: 22
HIV and COVID-19 Coinfection: A Synergism That Results in More Severe Forms of Reactive Arthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34925998/
Extra-Articular Manifestations in Reactive Arthritis due to COVID-19 (2021)
https://pubmed.ncbi.nlm.nih.gov/34765373/
Syndemic and syndemogenesis of low back pain in Latin-American population: a network and cluster analysis (2020)
https://pubmed.ncbi.nlm.nih.gov/32232735/
Association of ERAP2 polymorphisms in Colombian HLA-B27+ or HLA-B15+ patients with SpA and its relationship with clinical presentation: axial or peripheral predominance (2020)
https://pubmed.ncbi.nlm.nih.gov/32917832/
The Frequency of HLA-B27 in a Colombian Population with Signs of Spondyloarthritis (2018)
https://pubmed.ncbi.nlm.nih.gov/28356051/
Gastrointestinal Symptoms and Elevated Levels of Anti- Saccharomyces cerevisiae Antibodies Are Associated with Higher Disease Activity in Colombian Patients with Spondyloarthritis (2017)
https://pubmed.ncbi.nlm.nih.gov/29213287/
Association of human leukocyte A, B, and DR antigens in Colombian patients with diagnosis of spondyloarthritis (2017)
https://pubmed.ncbi.nlm.nih.gov/28013432/
Interobserver Agreement in Magnetic Resonance of the Sacroiliac Joints in Patients with Spondyloarthritis (2017)
https://pubmed.ncbi.nlm.nih.gov/28286523/
Analysis of HLA-B15 and HLA-B27 in spondyloarthritis with peripheral and axial clinical patterns (2015)
https://pubmed.ncbi.nlm.nih.gov/26560062/
The association between serum levels of potential biomarkers with the presence of factors related to the clinical activity and poor prognosis in spondyloarthritis (2012)
https://pubmed.ncbi.nlm.nih.gov/22885421/
Association of tumor necrosis factor alpha-308 promoter polymorphism with spondyloarthritides patients in Colombia (2012)
https://pubmed.ncbi.nlm.nih.gov/21833533/
Association between Th-17 cytokine profile and clinical features in patients with spondyloarthritis (2011)
https://pubmed.ncbi.nlm.nih.gov/22041179/
Epidemiology of spondyloarthritis in Colombia (2011)
https://pubmed.ncbi.nlm.nih.gov/21430445/
Serum monocyte chemotactic protein-1 concentrations distinguish patients with ankylosing spondylitis from patients with mechanical low back pain (2011)
https://pubmed.ncbi.nlm.nih.gov/20634732/
Identification of acute phase reactants and cytokines useful for monitoring infliximab therapy in ankylosing spondylitis (2008)
https://pubmed.ncbi.nlm.nih.gov/18566849/
Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with spondyloarthritis (2006)
https://pubmed.ncbi.nlm.nih.gov/17055360/
Low grade radiographic sacroiliitis as prognostic factor in patients with undifferentiated spondyloarthritis fulfilling diagnostic criteria for ankylosing spondylitis throughout follow up (2006)
https://pubmed.ncbi.nlm.nih.gov/16219705/
Association study of LMP gene polymorphisms in Mexican patients with spondyloarthritis (2004)
https://pubmed.ncbi.nlm.nih.gov/15603870/
Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies (2003)
https://pubmed.ncbi.nlm.nih.gov/12942696/
Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies (2003)
https://pubmed.ncbi.nlm.nih.gov/12942696/
Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients (2002)
https://pubmed.ncbi.nlm.nih.gov/12117677/
Use of a numerical rating scale as an answer modality in ankylosing spondylitis-specific questionnaires (2002)
https://pubmed.ncbi.nlm.nih.gov/12115152/
